These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The global state of prostate cancer: epidemiology and screening in the second millennium. Bono AV BJU Int; 2004 Dec; 94 Suppl 3():1-2. PubMed ID: 15521881 [No Abstract] [Full Text] [Related]
5. [Prostate cancer in Guadeloupe (French West Indies): incidence, mortality and clinicopathological features]. Brureau L; Multigner L; Wallois A; Verhoest G; Ndong JR; Fofana M; Blanchet P Bull Cancer; 2009 Feb; 96(2):165-70. PubMed ID: 19258223 [TBL] [Abstract][Full Text] [Related]
6. Progress in the control of prostate cancer in Rhode Island, 1987-2000. Chiaverini L; Fulton JP; Darcy DM Med Health R I; 2002 Sep; 85(9):291-3. PubMed ID: 12371217 [No Abstract] [Full Text] [Related]
7. New proposals from the EC with regard to public health. Eur J Cancer Care (Engl); 2000 Dec; 9(4):179-80. PubMed ID: 11829361 [No Abstract] [Full Text] [Related]
8. Chapter 5.4: major public health problems - cancer. Barlow L Scand J Public Health Suppl; 2006 Jun; 67():78-86. PubMed ID: 16762901 [No Abstract] [Full Text] [Related]
9. Screening for prostate cancer. Brawley OW; Ankerst DP; Thompson IM CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245 [TBL] [Abstract][Full Text] [Related]
10. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Etzioni R; Gulati R; Falcon S; Penson DF Med Decis Making; 2008; 28(3):323-31. PubMed ID: 18319508 [TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of prostate cancer and its implications in public health]. Richard F Rev Prat; 1994 Mar; 44(5):575-9. PubMed ID: 8066392 [TBL] [Abstract][Full Text] [Related]
12. [The risk of cancer in the Netherlands]. Kiemeney LA; Lemmers FA; Verhoeven RH; Aben KK; Honing C; de Nooijer J; Peeters PH; Visser O; Vlems FA Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2233-41. PubMed ID: 19009811 [TBL] [Abstract][Full Text] [Related]
13. Rising incidence of prostate cancer in Shanghai, China. Hsing AW; Devesa SS; Jin F; Gao YT Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):83-4. PubMed ID: 9456247 [No Abstract] [Full Text] [Related]
14. [Epidemiology and risk factors in prostatic cancer]. Swierz J; Stawarz B Wiad Lek; 1993 Sep; 46(17-18):680-2. PubMed ID: 7975605 [TBL] [Abstract][Full Text] [Related]
15. Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000. Demark-Wahnefried W; Schildkraut JM Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):415-6. PubMed ID: 11319187 [No Abstract] [Full Text] [Related]
16. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Telesca D; Etzioni R; Gulati R Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937 [TBL] [Abstract][Full Text] [Related]
18. Changes in baseline PSA levels in Japanese men from 1988 to 2003. Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775 [TBL] [Abstract][Full Text] [Related]